What is FreezeM?
FreezeM operates at the intersection of biotechnology and industrial agriculture, specializing in the development of innovative Black Soldier Fly (BSF) breeding solutions. The company addresses a fundamental bottleneck in the insect farming sector by providing life-cycle paused BSF neonates, a breakthrough that allows producers to optimize their operational efficiency and protein yield. Through its patented technological framework, FreezeM enables a more predictable and cost-effective production cycle, catering to both large-scale industrial facilities and decentralized waste management operations. By facilitating the conversion of organic bio-waste into high-value protein, the company serves as a cornerstone for circular economy initiatives, effectively bridging the gap between waste reduction and sustainable feed production.
How much funding has FreezeM raised?
FreezeM has raised a total of $14.2M across 1 funding round:
Series A
$14.2M
Series A (2024): $14.2M with participation from investor European Innovation Council Fund
Key Investors in FreezeM
European Innovation Council Fund
A venture capital arm of the European Commission that provides equity and quasi-equity investments to high-impact, deep-tech startups and SMEs.
What's next for FreezeM?
With the recent infusion of capital, FreezeM is expected to transition from its current scaling phase into a period of aggressive market penetration and infrastructure expansion. The strategic roadmap likely involves enhancing the global distribution network for its BSF neonates and further refining its automated breeding systems to meet the rising demand for sustainable animal feed alternatives. As the regulatory landscape for insect-derived protein continues to evolve, FreezeM's ability to maintain high-performing larvae production will be instrumental in securing long-term partnerships with major agricultural conglomerates and waste management entities. The company is poised to capitalize on the global shift toward sustainable food systems, leveraging its technological moat to maintain a competitive advantage in the burgeoning insect-tech market.
See full FreezeM company page
